194 related articles for article (PubMed ID: 15452226)
1. Structural and virological studies of the stages of virus replication that are affected by antirhinovirus compounds.
Zhang Y; Simpson AA; Ledford RM; Bator CM; Chakravarty S; Skochko GA; Demenczuk TM; Watanyar A; Pevear DC; Rossmann MG
J Virol; 2004 Oct; 78(20):11061-9. PubMed ID: 15452226
[TBL] [Abstract][Full Text] [Related]
2. Cryo-EM structure of pleconaril-resistant rhinovirus-B5 complexed to the antiviral OBR-5-340 reveals unexpected binding site.
Wald J; Pasin M; Richter M; Walther C; Mathai N; Kirchmair J; Makarov VA; Goessweiner-Mohr N; Marlovits TC; Zanella I; Real-Hohn A; Verdaguer N; Blaas D; Schmidtke M
Proc Natl Acad Sci U S A; 2019 Sep; 116(38):19109-19115. PubMed ID: 31462495
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and activity of piperazine-containing antirhinoviral agents and crystal structure of SDZ 880-061 bound to human rhinovirus 14.
Oren DA; Zhang A; Nesvadba H; Rosenwirth B; Arnold E
J Mol Biol; 1996 May; 259(1):120-34. PubMed ID: 8648640
[TBL] [Abstract][Full Text] [Related]
4. A novel benzonitrile analogue inhibits rhinovirus replication.
Lacroix C; Querol-Audí J; Roche M; Franco D; Froeyen M; Guerra P; Terme T; Vanelle P; Verdaguer N; Neyts J; Leyssen P
J Antimicrob Chemother; 2014 Oct; 69(10):2723-32. PubMed ID: 24948704
[TBL] [Abstract][Full Text] [Related]
5. VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds.
Ledford RM; Patel NR; Demenczuk TM; Watanyar A; Herbertz T; Collett MS; Pevear DC
J Virol; 2004 Apr; 78(7):3663-74. PubMed ID: 15016887
[TBL] [Abstract][Full Text] [Related]
6. The refined structure of human rhinovirus 16 at 2.15 A resolution: implications for the viral life cycle.
Hadfield AT; Lee Wm; Zhao R; Oliveira MA; Minor I; Rueckert RR; Rossmann MG
Structure; 1997 Mar; 5(3):427-41. PubMed ID: 9083115
[TBL] [Abstract][Full Text] [Related]
7. SDZ 35-682, a new picornavirus capsid-binding agent with potent antiviral activity.
Rosenwirth B; Oren DA; Arnold E; Kis ZL; Eggers HJ
Antiviral Res; 1995 Jan; 26(1):65-82. PubMed ID: 7741522
[TBL] [Abstract][Full Text] [Related]
8. Human rhinovirus 3 at 3.0 A resolution.
Zhao R; Pevear DC; Kremer MJ; Giranda VL; Kofron JA; Kuhn RJ; Rossmann MG
Structure; 1996 Oct; 4(10):1205-20. PubMed ID: 8939746
[TBL] [Abstract][Full Text] [Related]
9. Human rhinovirus capsid dynamics is controlled by canyon flexibility.
Reisdorph N; Thomas JJ; Katpally U; Chase E; Harris K; Siuzdak G; Smith TJ
Virology; 2003 Sep; 314(1):34-44. PubMed ID: 14517058
[TBL] [Abstract][Full Text] [Related]
10. The structure of human rhinovirus 16.
Oliveira MA; Zhao R; Lee WM; Kremer MJ; Minor I; Rueckert RR; Diana GD; Pevear DC; Dutko FJ; McKinlay MA
Structure; 1993 Sep; 1(1):51-68. PubMed ID: 7915182
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of the antirhinovirus flavanoid 4',6-dicyanoflavan.
Conti C; Tomao P; Genovese D; Desideri N; Stein ML; Orsi N
Antimicrob Agents Chemother; 1992 Jan; 36(1):95-9. PubMed ID: 1317152
[TBL] [Abstract][Full Text] [Related]
12. Insights into the genetic basis for natural phenotypic resistance of human rhinoviruses to pleconaril.
Ledford RM; Collett MS; Pevear DC
Antiviral Res; 2005 Dec; 68(3):135-8. PubMed ID: 16199099
[TBL] [Abstract][Full Text] [Related]
13. The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating.
Smith TJ; Kremer MJ; Luo M; Vriend G; Arnold E; Kamer G; Rossmann MG; McKinlay MA; Diana GD; Otto MJ
Science; 1986 Sep; 233(4770):1286-93. PubMed ID: 3018924
[TBL] [Abstract][Full Text] [Related]
14. Structure determination of antiviral compound SCH 38057 complexed with human rhinovirus 14.
Zhang A; Nanni RG; Li T; Arnold GF; Oren DA; Jacobo-Molina A; Williams RL; Kamer G; Rubenstein DA; Li Y
J Mol Biol; 1993 Apr; 230(3):857-67. PubMed ID: 8386772
[TBL] [Abstract][Full Text] [Related]
15. Antiviral agent blocks breathing of the common cold virus.
Lewis JK; Bothner B; Smith TJ; Siuzdak G
Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6774-8. PubMed ID: 9618488
[TBL] [Abstract][Full Text] [Related]
16. Novel pleconaril derivatives: Influence of substituents in the isoxazole and phenyl rings on the antiviral activity against enteroviruses.
Egorova A; Kazakova E; Jahn B; Ekins S; Makarov V; Schmidtke M
Eur J Med Chem; 2020 Feb; 188():112007. PubMed ID: 31881489
[TBL] [Abstract][Full Text] [Related]
17. Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses.
Badger J; Minor I; Oliveira MA; Smith TJ; Rossmann MG
Proteins; 1989; 6(1):1-19. PubMed ID: 2558377
[TBL] [Abstract][Full Text] [Related]
18. In-Silico screening of Pleconaril and its novel substituted derivatives with Neuraminidase of H1N1 Influenza strain.
Hussain Basha S; Prasad RN
BMC Res Notes; 2012 Feb; 5():105. PubMed ID: 22340192
[TBL] [Abstract][Full Text] [Related]
19. Lack of quantitative correlation between inhibition of replication of rhinoviruses by an antiviral drug and their stabilization.
Andries K; Dewindt B; Snoeks J; Willebrords R
Arch Virol; 1989; 106(1-2):51-61. PubMed ID: 2548460
[TBL] [Abstract][Full Text] [Related]
20. Modeling of the human rhinovirus C capsid suggests possible causes for antiviral drug resistance.
Basta HA; Ashraf S; Sgro JY; Bochkov YA; Gern JE; Palmenberg AC
Virology; 2014 Jan; 448():82-90. PubMed ID: 24314639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
